{"symbol":"BMY","fiscalQuarter":"Q1-2024","reportDate":"2024-04-25","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2024","postBrief":{"headline":"Bristol-Myers Squibb Misses on EPS, Stock Down 8.51%","keyNumbers":[{"metric":"EPS","actual":"$-4.40","expected":"N/A","surprise":"-387.21%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported a significant loss in EPS, which contributed to an 8.51% decline in stock price. The lack of revenue data and guidance leaves investors uncertain about the company's future performance. The large EPS miss suggests potential challenges that may need to be addressed in upcoming quarters.","metaDescription":"Bristol-Myers Squibb (BMY) Q1 2024 earnings: EPS missed. Stock down 8.51%. Full breakdown."}}